|
|
|
Sunday, March 21, 2010 — 1:30 p.m.
|
- Prognostication in Tumors of Soft Tissue and Bone
|
|
Moderator:
|
Christopher D.M. Fletcher, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
|
| Grading of Soft Tissue Sarcomas - From Histologic to Molecular Assessment - Jean-Michel Coindre, Institut Bergonie, Bordeaux, France |
| Histologic Grading of Bone Sarcomas - When And Why? - A. Kevin Raymond, MD Anderson Cancer Center, Houston, TX |
| Morphologically Benign Lesions of Soft Tissue and Bone Which Metastasize - What Can We Do? - Andrew L. Folpe, Mayo Clinic, Rochester, MN |
| The Prognostic Role of Immunohistochemistry in Sarcomas - Jason L. Hornick, Brigham & Women's Hospital, Boston, MA |
| Prognostication in GIST - A New Paradigm - Brian P. Rubin, Cleveland Clinic, Cleveland, OH |
| Prognostic and Predictive Molecular Testing in Soft Tissue Sarcomas - Where Do We Stand? - Marc Ladanyi, Memorial Sloan-Kettering Cancer Center, New York, NY |
|
|
|